These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge. Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, Peterson JW, Baker JR. Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384 [Abstract] [Full Text] [Related]
5. A new triple chimeric protein as a high immunogenic antigen against anthrax toxins: theoretical and experimental analyses. Abdous M, Hasannia S, Salmanian AH, Shahryar Arab S, Shali A, Alizadeh GA, Hajizadeh A, Khafri A, Mohseni A. Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):25-31. PubMed ID: 30621469 [Abstract] [Full Text] [Related]
6. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits. Lee DY, Chun JH, Ha HJ, Park J, Kim BS, Oh HB, Rhie GE. FEMS Immunol Med Microbiol; 2009 Nov; 57(2):165-72. PubMed ID: 19732139 [Abstract] [Full Text] [Related]
17. Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine. Marcus H, Danieli R, Epstein E, Velan B, Shafferman A, Reuveny S. Infect Immun; 2004 Jun; 72(6):3471-7. PubMed ID: 15155654 [Abstract] [Full Text] [Related]